Genome Medical, a San Francisco, CA-based genomics medical practice, raised new funding.
A Series A-1 round, which was led by GE Ventures with participation from Kaiser Permanente Ventures, Illumina Ventures and Canaan Partners, brought total funding to more than $23m.
Co-founded in 2016 by CEO Lisa Alderson, Randy Scott, PhD, and Robert Green, MD, MPH, Genome Medical operates a network of clinical genetics experts who leverage telehealth technology to deliver genetic counseling services in all 50 states and physician services — by medical geneticists and primary care providers — in 30 states (covering nearly three-quarters of the U.S. population).
The company will use the funds to expand all services nationwide in 2018, as well as deepen its clinical offerings in the areas of cancer genetics, cardiovascular genetics, reproductive health and proactive health.
In addition, the investment by strategic partners will support Genome Medical’s goal to extend its services to hospitals, health systems, large physician groups and employer groups.